No Data
No Data
No Data
Coherus BioSciences Completes Acquisition of Surface Oncology
Coherus Completes Surface Oncology Acquisition
Surface Oncology Says Takeover by Coherus BioSciences Gets Backing From ISS, Glass Lewis
Surface Oncology Announces ISS And Glass Lewis Both Recommend Stockholders Vote "FOR" The Proposed Merger With Coherus BioSciences >SURF
Surface Oncology GAAP EPS of -$0.46
Surface Oncology Q2 EPS $(0.46) Misses $(0.34) Estimate